Singapore markets closed

Aurora Cannabis Inc. (ACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.06+0.11 (+1.76%)
As of 10:06AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close5.95
Open6.01
Bid6.05 x 1800
Ask6.06 x 4000
Day's range5.89 - 6.09
52-week range3.71 - 18.98
Volume1,595,457
Avg. volume4,545,557
Market cap1.199B
Beta (5Y monthly)3.24
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • CNW Group

    Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2021, and file its related annual disclosure documen

  • CNW Group

    Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and full fiscal year 2021 on Tuesday, September 21, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2021 after the close of markets that same day.

  • CNW Group

    Aurora Cannabis Marks Successful Inaugural Fulfillment for French Pilot Program

    Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Ethypharm, have successfully delivered their initial shipment of cannabis to the French medical cannabis pilot program, set to begin serving patients in the coming weeks. Aurora and Ethypharm were selected by the National Agency for the Safety of Medicines and Health Products (ANSM) to supply the entire medical can